Analysis of the Epidemiological Situation of Hemorrhagic Fever with Renal Syndrome in the Russian Federation in 2022 and Forecast of its Development for 2023

The paper provides the analysis of epidemiological process of hemorrhagic fever with renal syndrome (HFRS) in the Russian Federation in the context of federal districts in 2022 and a forecast of the HFRS incidence for 2023. According to the results of the analysis, there was a three-fold increase in the morbidity rates of HFRS in Russia in 2022 as compared to the indicators of 2021. The evidence of epizootiological survey and laboratory studies in certain federal districts of the Russian Federation indicate the continuing tense epidemiological situation on HFRS. In a number of regions of the country, high risk of infection with HFRS is predicted due to the favorable natural and climatic conditions of the winter period 2022/2023 for reservoir hosts of pathogenic for humans Hantaviruses. The findings of infected rodents attest to a high probability of complication of the epidemiological situation in the territories of increased epidemic hazard as regards HFRS.

1. Heyman P., Vaheri A., Lundkvist A., Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev. Anti-infect. Ther. 2009; 7(2):205–17. DOI: 10.1586/14787210.7.2.205.

2. Lv C.X., An S.Y., Qiao B.J., Wu W. Time series analysis of hemorrhagic fever with renal syndrome in mainland China by using an XGBoost forecasting model. BMC Infect. Dis. 2021; 21(1):839. DOI: 10.1186/s12879-021-06503-y.

3. Jiang H., Zheng X., Wang L., Du H., Wang P., Bai X. Hantavirus infection: a global zoonotic challenge. Virol. Sin. 2017; 32(1):32–43. DOI: 10.1007/s12250-016-3899-x.

4. Xiao Y., Li Ya., Li Yu., Yu C., Bai Y., Wang L., Wang Y. Estimating the long-term epidemiological trends and seasonality of hemorrhagic fever with renal syndrome in China. Infect. Drug Resist. 2021; 14:3849–62. DOI: 10.2147/IDR.S325787.

5. Hamidon B.B., Saadiah S. Seoul hantavirus infection mimicking dengue fever. Med. J. Malaysia. 2003; 58(5):786–7.

6. Gamage C.D., Yasuda S.P., Nishio S., Kularatne S.A., Weerakoon K., Rajapakse J., Nwafor-Okoli C., Lee R.B., Obayashi Y., Yoshimatsu K., Arikawa J., Tamashiro H. Serological evidence of Thailand virus-related hantavirus infection among suspected leptospirosis patients in Kandy, Sri Lanka. Jpn. J. Infect. Dis. 2011; 64(1):72–5.

7. Lam S.K., Chua K.B., Myshrall T., Devi S., Zainal D., Afifi S.A., Nerome K., Chu Y.K., Lee H.W. Serological evidence of hantavirus infections in Malaysia. Southeast Asian J. Trop. Med. Public Health. 2001; 32(4): 809–13.

8. Surveillance Atlas of Infectious Diseases. (Cited 20 Mar 2023). [Internet]. Available from: http://atlas.ecdc.europa.eu/public/index.aspx.

9. Papa A. Dobrava-Belgrade virus: phylogeny, epidemiology, disease. Antiviral Res. 2012; 95(2):104–17. DOI: 10.1016/j.antiviral.2012.05.011.

10. Avšič Županc T., Korva M., Markotić A. HFRS and hantaviruses in the Balkans/South-East Europe. Virus Res. 2014; 187:27–33. DOI: 10.1016/j.virusres.2013.12.042.

11. Macé G., Feyeux C., Mollard N., Chantegret C., Audia S., Rebibou J.M. Spagnolo G., Bour J.B., Denoyel G.A., Sagot P., Reynes J.M. Severe Seoul hantavirus infection in a pregnant woman, France, October 2012. Euro Surveill. 2013; 18(17):20464.

12. Pan American Health Organization. (Cited 16 Mar 2023). [Internet]. Available from: https://www.paho.org/en.

13. Reported cases of Hantavirus disease. (Cited 20 Mar 2023). [Internet]. Available from: https://www.cdc.gov/hantavirus/surveillance/index.html.

14. Ministry of Health of Bolivia (Cited 20 Mar 2023). [Internet]. Available from: https://www.minsalud.gob.bo/6944-ministerio-de-salud-asiste-tecnica-y-normativamente-a-7-sedes-delpais-para-una-lucha-efectiva-contra-el-dengue.

15. Ministry of Health of the Republic of Panama. (Cited 20 Mar 2023). [Internet]. Available from: https://www.minsa.gob.pa.

16. Epidemiological situation. Hantavirus infection, Chile, 2022. (Cited 20 Mar 2023). [Internet]. Available from: http://epi.minsal.cl/wp-content/uploads/2023/03/Actualizacion-situacion-Epidemiologica-Hantavirus-ano-2022.pdf.

17. Ministry of Health of Argentina. (Cited 20 Mar 2023). [Internet]. Available from: https://www.argentina.gob.ar/noticias/elministerio-de-salud-confirma-el-fallecimiento-de-una-paciente-porhantavirus-en-chubut.

18. Witkowski P.T., Klempa B., Ithete N.L., Auste B., Mfune J.K., Hoveka J., Matthee S., Preiser W., Kruger D.H. Hantaviruses in Africa. Virus Res. 2014; 187:34–42. DOI: 10.1016/j.virusres.2013.12.039.

19. Witkowski P.T., Leendertz S.A., Auste B., Akoua-Koffi C., Schubert G., Klempa B., Muyembe-Tamfum J.J., Karhemere S., Leendertz F.H., Krüger D.H. Human seroprevalence indicating hantavirus infections in tropical rainforests of Côte d’Ivoire and Democratic Republic of Congo. Front. Microbiol. 2015; 6:518. DOI: 10.3389/fmicb.2015.00518.

20. Tkachenko E.A., Dzagurova T.K., Bernshtein A.D., Korotina N.A., Okulova N.M., Mutnykh E.S., Ivanov A.P., Ishmukhametov A.A., Yunicheva Yu.V., Pilikova O.M., Morozov V.G., Trankvilevsky D.V., Gorodin V.N., Bakhtina V.A., Sotskova S.E. [Hemorrhagic fever with renal syndrome (history, problems and prospects of research)]. Epidemiologiya i Vaktsinoprofilaktika [Epidemiology and Vaccinal Prevention]. 2016; 15(3):23–34. DOI: 10.31631/2073-3046-2016-15-3-23-34.

21. Kabwe E., Davidyuk Y., Shamsutdinov A., Garanina E., Martynova E., Kitaeva K., Malisheni M., Isaeva G., Savitskaya T., Urbanowicz R.A., Morzunov S., Katongo C., Rizvanov A., Khaiboullina S. Orthohantaviruses, emerging zoonotic pathogens. Pathogens. 2020; 9(9):775. DOI: 10.3390/pathogens9090775.

22. Plyusnin A., Morzunov S.P. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr. Top. Microbiol. Immunol. 2001; 256:47–75. DOI: 10.1007/978-3-642-56753-7_4.

23. Davidyuk Y., Shamsutdinov A., Kabwe E., Ismagilova R., Martynova E., Belyaev A., Shuralev E., Trifonov V., Savitskaya T., Isaeva G., Khaiboullina S., Rizvanov A., Morzunov S. Prevalence of the Puumala orthohantavirus strains in the Pre-Kama Area of the Republic of Tatarstan, Russia. Pathogens. 2020; 9(7):540. DOI: 10.3390/pathogens9070540.

24. Lundkvist A., Apekina N., Myasnikov Y., Vapalanti O., Vaheri A., Plusnin A. Dobrava hantavirus outbreak in Russia. Lancet. 1997; 350(9080):781–2. DOI: 10.1016/S0140-6736(05)62565-2.

25. Borodina Zh.I., Tsarenko O.E., Monakhov K.M., Bagautdinova L.I. [Hemorrhagic fever with renal syndrome: the challenge of our time]. Arkhiv Vnutrennei Meditsiny [The Russian Archives of Internal Medicine]. 2019; 9(6):419–27. DOI: 10.20514/2226-6704-2019-9-6-419-427.

26. Savitskaya T.A., Ivanova A.V., Chumachkova E.A., Pospelov M.V., Isaeva G.Sh., Reshetnikova I.D., Kabve E., Davidyuk Yu.N., Trifonov V.A., Ziatdinov V.B., Serova I.V. [Overview of hantavirus infections in the world, the epidemiological situation on hemorrhagic fever with renal syndrome in the Russian Federation in 2021, and forecast for 2022]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2022; (2):54–63. DOI: 10.21055/0370-1069-2022-2-54-63.

27. Ivanova A.V., Safronov V.A., Popov N.V., Kuklev E.V. [Epidemiological zoning of the Volga Federal District territory by the level of potential epidemic hazard of hemorrhagic fever with renal syndrome natural foci]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; (1):91–6. DOI: 10.21055/0370-1069-2020-1-91-96.